Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus

NCT07720310 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

12

Enrollment

OTHER_GOV

Sponsor class

Conditions

System Lupus Erythematosus(SLE)

Interventions

BIOLOGICAL: CAR T cells chimeric antigen receptor cells

Sponsor

N.N. Alexandrov National Cancer Centre

Collaborators

[object Object]